Analysis of Efficacy in in maintenance study including
BRCA WT
Forest Plot of PFS Hazard Ratios by subgroups – FDA analysis (ODAC briefing
book)
AstraZeneca subgroup
denomination
Overall
n=265
gBRCAm
n=96
gBRCA1m
n=70
gBRCA2m
n=26
sBRCAm
n=18
gBRCAwt
n=114
